COP29 is expected to spotlight climate finance as well as the mining’s role in ensuring a just energy transition.

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

Nikhila Shashikanth, a visionary pharmaceutical executive, has been appointed judge for the prestigious 2024 Global ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

Polaris faces a challenging 2024 but remains fundamentally strong, with a history of sales growth and resilient profitability ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

A 2021 Canadian study reported that 1,445 medicinal plant species are harvested for commercial products, 1,217 of which are ...

Pharmacists face growing challenges as Congress considers vital healthcare legislation to preserve access to community pharmacies.

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices. Trum ...

This article discusses continuous manufacturing and the increasing interest of this over traditional batch processing for ...

Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is ...